“A bout of exercise is like taking a little bit of Prozac and a little bit of Ritalin,” says John Ratey, “because it does the same thing.”
Mosquirix, developed by British drugmaker GlaxoSmithKline, has been given the green light by drug regulators in Europe.
Hot summer days are great for beachgoers, but they also endanger millions of lives. Heat is the No. 1 weather-related killer in the U.S.
Being diagnosed with cancer is difficult enough, but for African-Americans, the odds of surviving the disease are lower than whites.
The number of teenagers having sex is at the lowest level in 25 years. Less than half of 15 to 19-year-olds say they’ve had sex.
Alasdair Wilkins writes, “I wish I could have found a way to be comfortable in my skin even without the weight loss.”
The drug solanezumab showed some effectiveness in slowing the progression of the illness in people suffering from mild symptoms.
Researchers have made big strides in treating the rare genetic disorder known as Angelman Syndrome.
A conservative Silicon Valley Rotary Club would seem an unlikely candidate to be at the forefront of AIDS education.
It happens at hospitals every July: senior residents move on and a wave of around 30,000 new doctors begin their residencies.
One in every three kids in the U.S. is either overweight or obese. It’s even a problem in Colorado, one of the healthiest states.
Aetna, the fourth largest insurer in the U.S., bought its rival Humana for $37 billion. What does the merger mean for consumers?
Three new cases of the deadly virus have been found in Liberia, two months after the country was declared Ebola-free.
A multimillion dollar experiment is underway in Los Angeles: using health care dollars to house people who are chronically homeless.
The bill would get rid of the personal belief exemption, and require all children – except for those with medical wavers – to be vaccinated.